TERN - Terns Pharmaceuticals, Inc.

QQQ $ 476.00 $ 5.61 (1.19 %)

DIA $ 416.44 $ 2.30 (0.56 %)

SPY $ 563.62 $ 5.33 (0.95 %)

TLT $ 96.60 $ -1.04 (-1.07 %)

GLD $ 231.30 $ -1.66 (-0.71 %)

Previous Close

$ 7.62

Open

Bid

$ 7.61 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 3.26 - $ 10.03

Volume

628,054

Average Volume

Market Cap

536.23M

Beta (5Y Monthly)

$ 0.54

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	03-14-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-27-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-16-2022	03-31-2022	10-Q
11	03-07-2022	12-31-2021	10-K
12	11-15-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-14-2021	03-31-2021	10-Q
15	03-30-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Watching Shares Of Terns Pharmaceuticals; ...
08/15/2024 15:57:18

BMO Capital Reiterates Outperform on Terns...
08/06/2024 13:52:04

BMO Capital analyst Etzer Darout reiterates Terns Pharma (NASDAQ:TERN) with a Outperform and maintains $19 price target.

Terns Pharma Q2 EPS $(0.31) Beats $(0.34) ...
08/05/2024 20:23:57

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.34) ...

Terns Pharmaceuticals CFO Mark Vignola To ...
07/29/2024 20:28:09

CEO Amy Burroughs Highlights Kogan's Leadership And Industry Knowledge As Key To Growth; Bryan Yoon To Stay Through Septemb...

Kenneth Griffin Reports 5.3% Passive Stake...
07/22/2024 20:22:11

- SEC Filing

why-conagra-brands-shares-are-trading-lower-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why ConAgra Brands Shares Are Trading Lowe...
07/11/2024 18:02:49

methode-electronics-posts-strong-sales-joins-quantumscape-ribbon-communications-and-other-big-stocks-moving-higher-on-thursday

Methode Electronics Posts Strong Sales, Jo...
07/11/2024 14:10:16

Reported Earlier, Terns Pharmaceuticals Un...
06/24/2024 06:59:11

Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical compan...

HC Wainwright & Co. Reiterates Neutral on ...
05/14/2024 10:34:50

HC Wainwright & Co. analyst Ed Arce reiterates Terns Pharma (NASDAQ:TERN) with a Neutral and maintains $5.5 price target.

Terns Pharma Q1 2024 GAAP EPS $(0.30) Beat...
05/13/2024 12:14:08

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.34) ...

HC Wainwright & Co. Reiterates Neutral on ...
04/30/2024 16:46:35

HC Wainwright & Co. analyst Ed Arce reiterates Terns Pharma (NASDAQ:TERN) with a Neutral and maintains $5.5 price target.

JMP Securities Reiterates Market Outperfor...
04/30/2024 16:18:51

JMP Securities analyst Silvan Tuerkcan reiterates Terns Pharma (NASDAQ:TERN) with a Market Outperform and maintains $15 pric...

Terns Pharmaceuticals Announces Data from ...
04/29/2024 20:31:05

Ability to dose TERN-701 without regard to food represents a key potential differentiator within the allosteric BCR-ABL inhibit...

UBS Maintains Buy on Terns Pharma, Lowers ...
03/27/2024 18:17:00

UBS analyst Eliana Merle maintains Terns Pharma (NASDAQ:TERN) with a Buy and lowers the price target from $19 to $18.

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
03/21/2024 21:33:35

JMP Securities Maintains Outperform on Ter...
03/18/2024 11:01:51

JMP Securities analyst Silvan Tuerkcan maintains Terns Pharma (NASDAQ:TERN) with a Outperform and lowers the price target fr...

BMO Capital Maintains Outperform on Terns ...
03/15/2024 15:01:09

BMO Capital analyst Etzer Darout maintains Terns Pharma (NASDAQ:TERN) with a Outperform and raises the price target from $18...

HC Wainwright & Co. Reiterates Neutral on ...
03/15/2024 10:25:01

HC Wainwright & Co. analyst Ed Arce reiterates Terns Pharma (NASDAQ:TERN) with a Neutral and maintains $5.5 price target.

Terns Pharma Q4 EPS $(0.29), Inline
03/14/2024 20:15:12

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.29) per share which met the analyst consensus estimate. This is unc...

Terns Pharmaceuticals Secures FDA Orphan D...
03/11/2024 20:06:43

TERN-701, the Company's internally discovered allosteric BCR-ABL tyrosine kinase inhibitor (TKI), is in Phase 1 clinical de...